253 related articles for article (PubMed ID: 20542796)
1. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update.
Cuisset T; Valgimigli M; Mudra H; Muller O; Wijns W; Huber K
EuroIntervention; 2010 May; 6(1):39-45. PubMed ID: 20542796
[No Abstract] [Full Text] [Related]
2. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen KJ; Cuisset T; Kirchhof P; Marín F;
Thromb Haemost; 2010 Jan; 103(1):13-28. PubMed ID: 20062939
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification.
Patti G; Di Sciascio G
Catheter Cardiovasc Interv; 2010 Jan; 75(1):128-34. PubMed ID: 19670304
[TBL] [Abstract][Full Text] [Related]
4. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Rubboli A; Halperin JL
Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
[No Abstract] [Full Text] [Related]
5. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Roldán V; Marín F
Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
[No Abstract] [Full Text] [Related]
6. Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: balancing safety and efficacy.
Valgimigli M; Minarelli M
Am Heart J; 2010 Dec; 160(6 Suppl):S36-41. PubMed ID: 21147290
[TBL] [Abstract][Full Text] [Related]
7. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
May AE; Geisler T; Gawaz M
Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
[TBL] [Abstract][Full Text] [Related]
8. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting stent thrombosis.
Stähli BE; Camici GG; Tanner FC
Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
Milani RV
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064
[TBL] [Abstract][Full Text] [Related]
11. Thienopyridine antiplatelet agents: focus on prasugrel.
Freeman MK
Consult Pharm; 2010 Apr; 25(4):241-57. PubMed ID: 20511177
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
Nikolsky E; Mehran R; Stone GW
Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
[TBL] [Abstract][Full Text] [Related]
13. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
Wallén H; Agren A; Nekludov M
Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
[No Abstract] [Full Text] [Related]
14. Update on dual antiplatelet therapy for percutaneous coronary intervention.
Prasad A; Holmes DR
Heart; 2009 Jun; 95(11):861-5. PubMed ID: 19372090
[No Abstract] [Full Text] [Related]
15. Tug of war.
Manoukian SV
Am J Cardiol; 2009 Sep; 104(5 Suppl):1C-3C. PubMed ID: 19695353
[No Abstract] [Full Text] [Related]
16. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
Kandzari DE
Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
[TBL] [Abstract][Full Text] [Related]
17. Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?
Saucedo JF
Am J Cardiol; 2009 Sep; 104(5 Suppl):4C-8C. PubMed ID: 19695354
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet agents in acute coronary syndromes.
Sakhuja R; Yeh RW; Bhatt DL
Curr Probl Cardiol; 2010 Mar; 35(3):123-70. PubMed ID: 20152547
[TBL] [Abstract][Full Text] [Related]
19. Is the glass 97% full, or 3% empty? Reinfarction and stent thrombosis after STEMI.
Morrison DA
Catheter Cardiovasc Interv; 2009 Apr; 73(5):635-6. PubMed ID: 19309703
[No Abstract] [Full Text] [Related]
20. The score is in but is the decision final?
Brinker J
J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
